Supplement Recalls: What Triggers Them and How to Prevent One

What Triggers Supplement Recalls

Voluntary vs Mandatory Recalls

Most supplement recalls are voluntary. The company discovers a problem (or is informed of one) and initiates the recall. FDA can order a mandatory recall under FSMA (21 U.S.C. 350l) when it determines there is a reasonable probability the product is adulterated, or misbranded because its label does not declare a major food allergen, and exposure will cause serious adverse health consequences or death, and the company has had the opportunity to recall voluntarily and has not done so. Voluntary recalls generally result in better outcomes for the brand.

FDA classifies recalls into three categories:

The Recall Process Step by Step

• 1. Identify the problem. Determine what went wrong, which products are affected, and the potential health risk. This often starts with a complaint, test result, or internal quality check.
• 2. Determine scope. Identify affected lot numbers, production dates, and distribution channels. Batch records and lot traceability are critical here. Without them, you may need to recall all production, not just the affected batches.
• 3. Notify FDA. Notify the appropriate FDA district office immediately; FDA's recall regulation (21 CFR 7.46) requests this of a firm that recalls on its own. FDA will ask for the product's identity, the reason for the recall and how the problem was found, your risk evaluation, the amounts produced and still in distribution, distribution information, your recall communication, your proposed recall strategy, and a contact at your company.
• 4. Notify distribution partners. Alert retailers, distributors, 3PLs, and any other parties in your supply chain. Provide specific lot numbers and instructions for quarantining or returning affected products.
• 5. Public notification (if required). The recall strategy specifies whether a public warning is needed. FDA's recall regulation (21 CFR 7.42) reserves a public warning for a recalled product that presents a serious hazard to health, in urgent situations where other means of preventing its use appear inadequate; FDA, in consultation with the recalling firm, ordinarily issues it. If you issue your own warning, FDA asks to review it and your distribution plan first. Be transparent about the issue and what consumers should do.
• 6. Product retrieval. Collect affected products from the supply chain and consumers. Track retrieval rates. FDA asks the recalling firm for periodic recall status reports, generally every 2 to 4 weeks, covering how many consignees were notified and responded and how much product was returned or corrected, so it can assess the recall's progress (21 CFR 7.53).
• 7. Corrective action. Fix the root cause. This may involve changing manufacturers, updating testing protocols, modifying production processes, or improving quality controls. Document everything.
• 8. Documentation and closure. Maintain complete records of the recall: scope, notifications sent, products retrieved, corrective actions taken, and communication with FDA. These records may be reviewed in future inspections.

Financial Impact of a Recall

Recall costs vary widely. A 2009 GAO report on consumer products regulated by the Consumer Product Safety Commission said that “recalls can cost from a few thousand dollars to tens of millions of dollars,” citing a variety of sources. The cost depends on “the industry, product, and corrective action pursued.” That is not supplement-specific evidence, and the figures are not adjusted for inflation.

The ranges in the table below are Inventory Ready estimates from operating experience. Actual costs vary widely with distribution scope.

Prevention Framework

A recall’s cost is hard to predict and can run high, so build these practices into your operations from day one:

• Raw material testing. Identity-test every incoming dietary ingredient (required by 21 CFR 111.75(a)(1)(i), “unless you petition the agency under paragraph (a)(1)(ii) of this section and the agency exempts you from such testing”) and test raw materials for contaminants per your specifications. Do not rely solely on your supplier's COA for dietary ingredients; for other components, a qualified supplier's COA that you periodically re-confirm is permitted (111.75(a)(2)). Independent verification catches problems before they enter your product.
• Finished product testing. Test every batch of finished product through an ISO 17025 accredited third-party lab before release. This includes potency, identity, heavy metals, and microbial testing.
• Supplier qualification. Qualify every ingredient supplier through documented evaluation: certifications, audit history, testing capabilities, and references. Requalify annually.
• Allergen control program. If your products contain any of the nine major allergens recognized by FDA, establish written allergen control procedures. The nine include the eight traditional allergens plus sesame, added under the FASTER Act effective January 1, 2023. The same applies if products are produced on shared equipment. Test finished products for undeclared allergens.
• Batch record review. Review batch production records before releasing any product. Verify that all steps were followed, all testing was completed, and all results meet specifications.
• Quality agreement enforcement. Your quality agreement with your manufacturer should specify testing requirements, deviation handling, and notification procedures. Review and enforce it regularly.

For more on testing requirements, see our testing requirements guide and quality agreements guide.